Support The World's Smartest Network

Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.

This site uses cookies.
Learn more.


This website uses cookies. Some of the cookies we use are essential for parts of the website to operate while others offer you a better browsing experience. You give us your permission to use cookies, by continuing to use our website after you have received the cookie notification. To find out more about cookies on this website and how to change your cookie settings, see our Privacy policy and Terms of Use.

We encourage you to learn more about cookies on our site in our Privacy policy and Terms of Use.

Sherin Al-Safadi

Sherin Al-Safadi

Global Medical Affairs Strategy

Bayer Pharmaceuticals

Sherin Al-Safadi is currently pursuing her passion for innovative patient-centric healthcare and translational medicine with the Bayer Global team, as a Medical Affairs Oncology Strategy Lead. Sherin attended McGill University where she completed a B.Sc. in Anatomy & Cell Biology and M.Sc. in Pharmacology & Therapeutics. With the aspiration of transitioning from academia to the pharmaceutical industry, she then obtained her MBA (Entrepreneurship & Management) and PhD in Neurobiology from Concordia University. Sherin began her professional journey with Bayer Canada and spent several years with the Oncology team, in advisor and managerial roles prior to relocating to the US.

Outside of work, Sherin is a proactive philanthropist with a passion for driving social change. She co-founded and leads Fondation Amal, a Montreal-based non-profit that fundraises and advocates for improving the quality of life of kids with chronic disease and disabilities, through a new generation of young philanthropists. Sherin is also a competitive kickboxer; she has learnt the toughest life lessons in the ring and continues to apply them in her personal and professional lives.